The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 39 | 31.4x | 20.1x | Near average | |
Growth | 69 | 7.6% | 5.6% | Above average | |
Quality | 63 | 9.4% | 7.6% | Near average | |
Safety | 51 | 1.6x | 0.4x | Near average | |
Capital Return | 80 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
HealthEquity, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy HealthEquity, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
HealthEquity stock has seen notable stability in its average price target at $109.82, with very slight downward adjustments of -0.16% over the past 30 days. Despite a new analyst joining the coverage recently, the Consensus remained steady, indicating a unified view among analysts regarding the stock's fair value, with a positive price gap compared to the current price ($85.21).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.